A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studiesWen‐Zhen Gu, Haiying Zhang, David J. Frost et al.|Anti-Cancer Drugs|2005Cited by 7
Development of ABT-806i, a Kit-formulated 111In-ABT-806 antibody directed to EGFR for tumor imagingEdward B. Reilly, Todd Cole, Andrew C. Phillips et al.|Journal of Nuclear Medicine|2013Cited by 0